Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomas

Cancer Letters

Volumn 335, Issue 2, 2013, Pages 314-322

  Mach, Claire M ^a,b   Kim, Jong ^a   Soibam, Benjamin ^c   Creighton, Chad J ^a   Hawkins, Shannon M ^a   Zighelboim, Israel ^d   Goodfellow, Paul ^d   Gunaratne, Preethi H ^a,c   Odunsi, Kunle ^e   Salem, Philip A ^f   Anderson, Matthew L ^a,f  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c University of Houston   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Focal adhesions; MicroRNA; Migration; Uterine cancer; Vinculin

Indexed keywords

MICRORNA; VINCULIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; ENDOMETRIUM CARCINOMA; FEMALE; FOCAL ADHESION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA EXTRACTION; RNA SEQUENCE; RNA TRANSCRIPTION;

ADENOCARCINOMA; APOPTOSIS; BASE SEQUENCE; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA;

EID: 84878258220     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.043     Document Type: Article

References (42)

1. Siegel R., DeSantis C., Virgo K., Stein K., Mariotto A., Smith T., Cooper D., Gansler T., Lerro C., Fedewa S., Lin C., Leach C., Cannady R.S., Cho H., Scoppa S., Hachey M., Kirch R., Jemal A., Ward E. Cancer treatment and survivorship statistics. CA Cancer J. Clin. 2012, 62(2012):220-241.
2. Slack F.J., Weidhaas J.B. MicroRNA in cancer prognosis. New Engl. J. Med. 2008, 359:2720-2722.
3. Lam E.W., Shah K., Brosens J.J. The diversity of sex steroid action: the role of micro-RNAs and FOXO transcription factors in cycling endometrium and cancer. J. Endocrinol. 2012, 212:13-25.
4. Hawkins S.M., Creighton C.J., Han D.Y., Zariff A., Anderson M.L., Gunaratne P.H., Matzuk M.M. Functional MicroRNA Involved in endometriosis. Mol. Endocrinol. 2011, 25:821-832.
5. Filigheddu N., Gregnanin I., Porporato P.E., Surico D., Perego B., Galli L., Patrignani C., Graziani A., Surico N. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J. Biomed. Biotechnol. 2010, 2010:369549.
6. Pan Q., Luo X., Toloubeydokhti T., Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol. Human Reprod. 2007, 13:797-806.
7. Devor E.J., Hovey A.M., Goodheart M.J., Ramachandran S., Leslie K.K. MicroRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs. Oncol. Rep. 2011, 26:995-1002.
8. Pan Q., Luo X., Chegini N. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J. Cell. Mol. Med. 2008, 12:227-240.
9. Zighelboim I., Reinhart A.J., Gao F., Schmidt A.P., Mutch D.G., Thaker P.H., Goodfellow P.J. DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma. Cancer 2011, 117:1446-1453.
10. Fader A.N., Boruta D., Olawaiye A.B., Gehrig P.A. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr. Opin. Obstet. Gynecol. 2010, 22:21-29.
11. Zheng W., Xiang L., Fadare O., Kong B. A proposed model for endometrial serous carcinogenesis. Am. J. Surg. Pathol. 2011, 35:e1-e14.
12. Fadare O., Liang S.X., Ulukus E.C., Chambers S.K., Zheng W. Precursors of endometrial clear cell carcinoma. Am. J. Surg. Pathol. 2006, 30:1519-1530.
13. Zheng W., Liang S.X., Yu H., Rutherford T., Chambers S.K., Schwartz P.E. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: Morphologic features. Int. J. Surg. Pathol. 2004, 12:207-223.
14. Liang S.X., Chambers S.K., Cheng L., Zhang S., Zhou Y., Zheng W. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: Molecular features. Int. J. Surg. Pathol. 2004, 12:319-331.
15. Creighton C.J., Benham A.L., Zhu H., Khan M.F., Reid J.G., Nagaraja A.K., Fountain M.D., Dziadek O., Han D., Ma L., Kim J., Hawkins S.M., Anderson M.L., Matzuk M.M., Gunaratne P.H. Discovery of novel microRNAs in female reproductive tract using next generation sequencing. PLoS One 2010, 5:e9637.
16. Helvik S.A., Snove O., Saetrom P. Reliable prediction of Drosha processing sites improves microRNA gene prediction. Bioinformatics 2007, 23:142-149.
17. Maragkakis M., Alexiou P., Papadopoulos G.L., Reczko M., Dalamagas T., Giannopoulos G., Goumas G., Koukis E., Kourtis K., Simossis V.A., Sethupathy P., Vergoulis T., Koziris N., Sellis T., Tsanakas P., Hatzigeorgiou A.G. Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinf. 2009, 10:295.
18. Hubisz M.J., Pollard K.S., Siepel A. PHAST and RPHAST: phylogenetic analysis with space/time models. Briefings Bioinf. 2011, 12:41-51.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.) 2001, 25:402-408.
20. Cross S.N., Cocco E., Bellone S., Anagnostou V.K., Brower S.L., Richter C.E., Siegel E.R., Schwartz P.E., Rutherford T.J., Santin A.D. Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro. Am. J. Obstet. Gynecol. 2010, 203:e161-e168. 162.
21. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protocols 2007, 2:329-333.
22. Creighton C.J., Fountain M.D., Yu Z., Nagaraja A.K., Zhu H., Khan M., Olokpa E., Zariff A., Gunaratne P.H., Matzuk M.M., Anderson M.L. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res. 2010, 70:1906-1915.
23. Ambros V., Bartel B., Bartel D.P., Burge C.B., Carrington J.C., Chen X., Dreyfuss G., Eddy S.R., Griffiths-Jones S., Marshall M., Matzke M., Ruvkun G., Tuschl T. A uniform system for microRNA annotation. RNA 2003, 9:277-279.
24. Stark M.S., Tyagi S., Nancarrow D.J., Boyle G.M., Cook A.L., Whiteman D.C., Parsons P.G., Schmidt C., Sturm R.A., Hayward N.K. Characterization of the melanoma miRNAome by deep sequencing. PLoS One 2010, 5:e9685.
25. Maragkakis M., Reczko M., Simossis V.A., Alexiou P., Papadopoulos G.L., Dalamagas T., Giannopoulos G., Goumas G., Koukis E., Kourtis K., Vergoulis T., Koziris N., Sellis T., Tsanakas P., Hatzigeorgiou A.G. DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 2009, 37:W273-276.
26. Wong A.S., Pelech S.L., Woo M.M., Yim G., Rosen B., Ehlen T., Leung P.C., Auersperg N. Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?. Oncogene 2001, 20:1318-1328.
27. Berrier A.L., Mastrangelo A.M., Downward J., Ginsberg M., LaFlamme S.E. Activated R-ras, Rac1, PI 3-kinase and PKCepsilon can each restore cell spreading inhibited by isolated integrin beta1 cytoplasmic domains. J. Cell Biol. 2000, 151:1549-1560.
28. Integrated genomic analyses of ovarian carcinoma. Nature 474 (2011) 609-615.
29. Ezzell R.M., Goldmann W.H., Wang N., Parashurama N., Ingber D.E. Vinculin promotes cell spreading by mechanically coupling integrins to the cytoskeleton. Exp. Cell Res. 1997, 231:14-26.
30. Slack F.J., Basson M., Liu Z., Ambros V., Horvitz H.R., Ruvkun G. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor. Mol. Cell 2000, 5:659-669.
31. Aravin A., Tuschl T. Identification and characterization of small RNAs involved in RNA silencing. FEBS Lett. 2005, 579:5830-5840.
32. Fu H., Tie Y., Xu C., Zhang Z., Zhu J., Shi Y., Jiang H., Sun Z., Zheng X. Identification of human fetal liver miRNAs by a novel method. FEBS Lett. 2005, 579:3849-3854.
33. Stark A., Lin M.F., Kheradpour P., Pedersen J.S., Parts L., Carlson J.W., Crosby M.A., Rasmussen M.D., Roy S., Deoras A.N., Ruby J.G., Brennecke J., Hodges E., Hinrichs A.S., Caspi A., Paten B., Park S.W., Han M.V., Maeder M.L., Polansky B.J., Robson B.E., Aerts S., van Helden J., Hassan B., Gilbert D.G., Eastman D.A., Rice M., Weir M., Hahn M.W., Park Y., Dewey C.N., Pachter L., Kent W.J., Haussler D., Lai E.C., Bartel D.P., Hannon G.J., Kaufman T.C., Eisen M.B., Clark A.G., Smith D., Celniker S.E., Gelbart W.M., Kellis M. Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures. Nature 2007, 450:219-232.
34. Elemento O., Tavazoie S. Fastcompare: a nonalignment approach for genome-scale discovery of DNA and mRNA regulatory elements using network-level conservation. Methods Mol. Biol. 2007, 395:349-366.
35. Schotte D., Moqadam F.A., Lange-Turenhout E.A., Chen C., van Ijcken W.F., Pieters R., den Boer M.L. Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia. Leukemia 2011, 25:1389-1399.
36. Burnside J., Ouyang M., Anderson A., Bernberg E., Lu C., Meyers B.C., Green P.J., Markis M., Isaacs G., Huang E., Morgan R.W. Deep sequencing of chicken microRNAs. BMC Genomics 2008, 9:185.
37. Morin R.D., O'Connor M.D., Griffith M., Kuchenbauer F., Delaney A., Prabhu A.L., Zhao Y., McDonald H., Zeng T., Hirst M., Eaves C.J., Marra M.A. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 2008, 18:610-621.
38. Berezikov E., Cuppen E., Plasterk R.H. Approaches to microRNA discovery. Nat. Genet. 2006, 38(Suppl.):S2-7.
39. Chiang H.R., Schoenfeld L.W., Ruby J.G., Auyeung V.C., Spies N., Baek D., Johnston W.K., Russ C., Luo S., Babiarz J.E., Blelloch R., Schroth G.P., Nusbaum C., Bartel D.P. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev. 2010, 24:992-1009.
40. Subauste M.C., Nalbant P., Adamson E.D., Hahn K.M. Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2. J. Biol. Chem. 2005, 280:5676-5681.
41. Ayaki M., Komatsu K., Mukai M., Murata K., Kameyama M., Ishiguro S., Miyoshi J., Tatsuta M., Nakamura H. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin. Cancer Res.: An Off. J. Am. Assoc. Cancer Res. 2001, 7:3106-3112.
42. Raz A., Geiger B. Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res. 1982, 42:5183-5190.